| | | |  | | | | By Mohana Ravindranath Adobe Health systems are using machine learning to predict which patients will have the highest health care costs. Can it help patients? Read More | | By Ed Silverman Andrew Harnik/AP The Justice Department is seeking information about activities in which Bausch Health medicines may have been promoted for unapproved uses. Read More | | By Ed Silverman Ruby Wallau for STAT The existing cost of care is “expensive enough that there are big offsets to having a one-time therapy," said David Rind of ICER. Read More | | Sponsor content by STAT TRIALS PULSE How a biotech startup is using AI tools to redefine how they approach clinical development Artificial Intelligence is transforming the way small biotechs are scaling their businesses. In our latest case study of Feldan Therapeutics, we show how STAT Trials Pulse has become a game-changer for them, helping accelerate data-gathering, better analyze their competitors, and streamline their operations. Read the case. | | By Angus Chen Courtesy Kristin Anderson The work, while very early, pushes at the boundary of what might be possible – and practical – to do in immunotherapy. Read More | | By Patrick Skerrett This week's "First Opinion Podcast" covers the collision between the pandemic-related mental health crisis and the shortage of psychiatrists. Read More | | By Adam Feuerstein Kirsty Wigglesworth/AP The deal was struck three months after Sierra’s lead drug, a treatment for the blood cancer myelofibrosis, succeeded in a late-stage trial. Read More | | By Theresa Gaffney Alex Hogan/STAT STAT spoke with Rhea Boyd, a pediatrician and health equity advocate, about her work in the clinic and in the community. Read More | | By Jonathan Wosen Adobe Halozyme is pursuing a strategy that’s proven profitable — developing quick, convenient ways to deliver drugs to patients. Read More | |
No comments